StocksFundsScreenerSectorsWatchlists
MMSI

MMSI - Merit Medical Systems Inc Stock Price, Fair Value and News

71.51USD-1.24 (-1.70%)Market Closed

Market Summary

MMSI
USD71.51-1.24
Market Closed
-1.70%

MMSI Alerts

  • 1 major insider sales recently.

MMSI Stock Price

View Fullscreen

MMSI RSI Chart

MMSI Valuation

Market Cap

4.1B

Price/Earnings (Trailing)

43.88

Price/Sales (Trailing)

3.29

EV/EBITDA

20.12

Price/Free Cashflow

37.37

MMSI Price/Sales (Trailing)

MMSI Profitability

EBT Margin

8.91%

Return on Equity

7.85%

Return on Assets

4.06%

Free Cashflow Yield

2.68%

MMSI Fundamentals

MMSI Revenue

Revenue (TTM)

1.3B

Rev. Growth (Yr)

10.6%

Rev. Growth (Qtr)

2.95%

MMSI Earnings

Earnings (TTM)

94.4M

Earnings Growth (Yr)

-17.28%

Earnings Growth (Qtr)

6.95%

Breaking Down MMSI Revenue

Last 7 days

-0.7%

Last 30 days

-1.0%

Last 90 days

-9.0%

Trailing 12 Months

-6.1%

How does MMSI drawdown profile look like?

MMSI Financial Health

Current Ratio

5.45

Debt/Equity

0.68

Debt/Cashflow

0.18

MMSI Investor Care

Shares Dilution (1Y)

1.07%

Diluted EPS (TTM)

1.63

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20231.2B1.2B1.2B1.3B
20221.1B1.1B1.1B1.2B
2021969.3M1.0B1.1B1.1B
20201.0B962.9M963.8M963.9M
2019918.1M948.8M970.2M994.9M
2018759.8M798.1M840.4M882.8M
2017636.8M672.3M694.7M727.9M
2016550.6M563.6M584.5M603.8M
2015520.0M529.2M536.5M542.1M
2014464.3M483.3M496.9M509.7M
2013402.6M412.0M431.3M449.0M
2012368.4M377.7M383.1M394.3M
2011316.0M332.3M349.6M359.4M
20100270.6M283.7M296.8M
2009000257.5M
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Merit Medical Systems Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Mar 14, 2024
lloyd brian g.
gifted
-
-
-1,180
chief legal officer, secretary
Mar 12, 2024
parra raul jr.
sold
-479,182
73.9479
-6,480
cfo and treasurer
Mar 07, 2024
wright joseph
acquired
705,000
28.2
25,000
chief commercial officer
Mar 07, 2024
wright joseph
sold
-1,891,920
75.677
-25,000
chief commercial officer
Mar 06, 2024
peterson neil
acquired
336,000
44.8
7,500
chief operating officer
Mar 06, 2024
voigt michel james
gifted
-
-
-315
chief human resources officer
Mar 04, 2024
voigt michel james
sold (taxes)
-201,221
76.51
-2,630
chief human resources officer
Mar 04, 2024
wright joseph
sold (taxes)
-201,221
76.51
-2,630
chief commercial officer
Mar 04, 2024
wright joseph
acquired
-
-
14,429
chief commercial officer
Mar 04, 2024
gunderson thomas james
sold
-1,380,510
76.032
-18,157
-

1–10 of 50

Which funds bought or sold MMSI recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 15, 2024
EXCHANGE TRADED CONCEPTS, LLC
new
-
1,461,820
1,461,820
0.04%
Apr 12, 2024
AdvisorNet Financial, Inc
sold off
-100
-836
-
-%
Apr 11, 2024
CONGRESS ASSET MANAGEMENT CO /MA
added
4,411
38,402,200
39,275,200
0.28%
Apr 09, 2024
MASSMUTUAL TRUST CO FSB/ADV
added
1.71
127
9,014
-%
Apr 08, 2024
TOMPKINS FINANCIAL CORP
sold off
-100
-37,980
-
-%
Apr 05, 2024
CWM, LLC
reduced
-6.98
-4,000
41,000
-%
Apr 05, 2024
GAMMA Investing LLC
added
52.44
8,364
25,982
-%
Apr 03, 2024
Versant Capital Management, Inc
unchanged
-
-6.00
2,045
-%
Mar 29, 2024
Kapitalo Investimentos Ltda
new
-
95,862
95,862
0.02%
Mar 27, 2024
NOMURA HOLDINGS INC
new
-
346,226
346,226
-%

1–10 of 49

Are Funds Buying or Selling MMSI?

Are funds buying MMSI calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own MMSI
No. of Funds

Unveiling Merit Medical Systems Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
11.92%
6,884,723
SC 13G/A
Feb 12, 2024
william blair investment management, llc
6.6%
3,791,089
SC 13G/A
Jan 22, 2024
blackrock inc.
17.4%
10,067,008
SC 13G/A
Feb 15, 2023
arrowmark colorado holdings llc
4.42%
2,517,226
SC 13G/A
Feb 09, 2023
william blair investment management, llc
6.6%
3,729,980
SC 13G/A
Feb 09, 2023
vanguard group inc
11.99%
6,824,344
SC 13G/A
Jan 26, 2023
blackrock inc.
17.0%
9,670,688
SC 13G/A
Jan 20, 2023
blackrock inc.
17.0%
9,670,688
SC 13G/A
Feb 14, 2022
arrowmark colorado holdings llc
5.51%
3,111,000
SC 13G/A
Feb 10, 2022
william blair investment management, llc
5.9%
3,357,638
SC 13G/A

Recent SEC filings of Merit Medical Systems Inc

View All Filings
Date Filed Form Type Document
Apr 02, 2024
ARS
ARS
Apr 02, 2024
ARS/A
ARS/A
Apr 02, 2024
DEF 14A
DEF 14A
Apr 02, 2024
DEFA14A
DEFA14A
Mar 15, 2024
4
Insider Trading
Mar 13, 2024
4
Insider Trading
Mar 12, 2024
144
Notice of Insider Sale Intent
Mar 08, 2024
4
Insider Trading
Mar 08, 2024
4
Insider Trading
Mar 06, 2024
4
Insider Trading

Peers (Alternatives to Merit Medical Systems Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
183.7B
40.1B
-5.83% 1.66%
32.1
4.58
-8.12% -17.45%
67.1B
19.5B
-2.32% -8.43%
53.41
3.44
4.02% -22.04%
22.6B
3.9B
-4.99% -13.70%
50.69
5.84
3.42% 23.09%
20.1B
14.8B
-4.86% -7.71%
7.56
1.35
2.12% 209.17%
MID-CAP
9.1B
3.5B
-0.64% 16.68%
32.12
2.62
4.97% 18.89%
9.0B
12.3B
-5.34% -15.09%
21.69
0.73
-2.44% -22.68%
8.5B
2.7B
-12.68% -39.24%
-13.34
3.18
-4.68% 82.43%
6.3B
4.0B
-7.94% -25.15%
-46.81
1.59
1.10% 85.84%
3.4B
366.4M
-1.55% 17.10%
-564.74
9.35
33.86% 89.83%
2.3B
6.6B
-3.92% -2.28%
11.91
0.35
2.78% -0.87%
SMALL-CAP
1.3B
3.2B
-5.32% -19.06%
-1.85
0.39
7.73% -1066.14%
381.5M
166.7M
1.82% -7.51%
-4.61
2.29
6.67% -456.34%
253.5M
324.0M
17.44% -27.90%
-1.32
0.78
-3.19% -337.41%
45.7M
52.3M
-25.42% -56.00%
-2.44
0.87
17.61% 19.28%
3.7M
3.7M
-14.97% 255.00%
-0.3
0.99
5.77% 8.23%

Merit Medical Systems Inc News

Latest updates
MarketBeat3 hours ago
Simply Wall St02 Apr 202407:00 am

Merit Medical Systems Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue2.9%325315320298293287295275278267280249258244218244258243256238233
Gross Profit5.9%15114215313813512913512112912012411211110284.00104112104112105105
Operating Expenses9.2%11710712411210411011210610710511598.0095.0010210310211510710095.0091.00
  S&GA Expenses10.2%96.0087.0010190.0083.0090.0085.0084.0077.0086.0092.0081.0080.0072.0067.0079.0082.0087.0080.0078.0076.00
  R&D Expenses-------------------16.0016.0015.00
EBITDA Margin0.9%0.17*0.17*0.16*0.16*0.15*0.14*0.14*0.13*0.13*0.13*0.12*0.11*---------
Interest Expenses2.8%5.005.004.002.002.002.001.001.001.001.001.002.002.002.003.003.003.003.003.003.002.00
Income Taxes-12.5%4.004.005.005.00-3.252.005.004.00-0.432.002.002.00-2.131.00-3.241.00-3.76-2.292.001.003.00
Earnings Before Taxes4.1%31.0030.0025.0026.0030.0018.0021.0014.0020.0014.007.0013.0013.00-2.18-22.30-1.99-7.96-5.699.007.0012.00
EBT Margin-1.3%0.09*0.09*0.08*0.08*0.07*0.06*0.06*0.05*0.05*0.04*0.03*0.00*---------
Net Income6.9%28.0026.0020.0021.0033.0015.0015.0011.0021.0012.005.0011.0015.00-3.01-19.06-3.15-4.20-3.407.006.009.00
Net Income Margin-8.1%0.08*0.08*0.07*0.07*0.06*0.05*0.05*0.04*0.05*0.04*0.03*0.00*---------
Free Cashflow29.8%55.0042.0012.002.0016.0020.0032.002.0037.0018.0035.0029.00---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets28.6%2,3251,8091,8381,6841,6641,6331,6321,6301,6481,6431,6421,6521,6641,6711,7161,7491,7571,7621,7361,6901,620
  Current Assets89.4%1,108585595557529500493478482463450438430435446463455441427422430
    Cash Equivalents900.5%58759.0072.0058.0058.0051.0063.0054.0068.0069.0070.0059.0057.0045.0050.0050.0044.0037.0035.0050.0067.00
  Inventory0.0%304304306290266247233231222208195200198209221228226217203199198
  Net PPE0.1%384383384387383376371372372373374378383384384385379367351341331
  Goodwill0.3%382381382360360358360361362362363363364354353352353352352--
Liabilities94.1%1,123579634512520544558573608630650675706737787809807812786750687
  Current Liabilities8.8%204187190216221213196204236213211208185186174165182153177178175
  Long Term Debt191.5%823282335186187205236243234271285313344350403438432432385362373
    LT Debt, Current-100.0%-4.004.0011.0011.0011.0010.009.008.008.008.008.008.008.008.008.008.008.0015.0022.0022.00
    LT Debt, Non Current191.5%823282335186187205236243234271285313344350403438432432385362373
Shareholder's Equity-2.3%1,2021,2301,2041,1721,1441,0891,0731,0571,0401,013992977959934929940950949951940933
  Retained Earnings5.0%575548522501481447432417406386374369358342345364368373377370363
Accumulated Depreciation0.5%329327320311303300294288281277273266261255248239232230222215210
Shares Outstanding0.2%58.0058.0058.0057.0057.0057.0057.0057.0056.0056.0056.0056.00---------
Float---4,700---3,000---3,600---2,500---3,200--
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations21.9%62,25151,06917,28614,54528,00835,48938,78412,01045,81524,97641,20835,23236,91555,13944,35228,86426,90915,21422,18513,50523,676
  Share Based Compensation3.3%5,9875,7975,5803,9694,3514,5984,4514,6424,5014,8573,1373,5954,0714,0633,4282,7772,4672,6262,5231,7661,623
Cashflow From Investing9.8%-8,343-9,253-142,895-14,856-17,329-16,769-13,431-9,868-14,607-7,294-8,912-6,348-21,871-9,365-12,654-14,762-20,567-39,114-53,753-21,047-196,049
Cashflow From Financing966.7%472,810-54,553141,506-497-5,749-27,067-13,204-14,240-32,469-17,891-21,829-26,246-4,548-51,976-32,948-6,234-16725,93717,584-9,821187,920

MMSI Income Statement

2023-12-31
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
CONSOLIDATED STATEMENTS OF INCOME   
Net sales$ 1,257,366$ 1,150,981$ 1,074,751
Cost of sales673,494631,882589,418
Gross profit583,872519,099485,333
Operating expenses:   
Selling, general and administrative373,676342,525335,690
Research and development82,72875,51071,247
Legal settlement  10,036
Impairment charges2702,2194,283
Contingent consideration expense1,7044,6113,161
Acquired in-process research and development1,5506,671 
Total operating expenses459,928431,536424,417
Income from operations123,94487,56360,916
Other income (expense):   
Interest income2,456439769
Interest expense(15,511)(6,339)(5,261)
Other income (expense) - net1,200966(2,507)
Total other expense - net(11,855)(4,934)(6,999)
Income before income taxes112,08982,62953,917
Income tax expense17,6788,1135,463
Net income$ 94,411$ 74,516$ 48,454
Earnings per common share   
Basic (in dollars per share)$ 1.64$ 1.31$ 0.86
Diluted (in dollars per share)$ 1.62$ 1.29$ 0.84
Weighted average shares outstanding   
Basic (in shares)57,59356,80656,145
Diluted (in shares)58,35657,67157,359

MMSI Balance Sheet

2023-12-31
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 587,036$ 58,408
Trade receivables - net of allowance for credit losses - 2023 - $8,721 and 2022 - $8,423177,885164,677
Other receivables10,51712,992
Inventories303,871265,991
Prepaid expenses and other current assets24,28622,324
Prepaid income taxes4,0163,913
Income tax refund receivables859779
Total current assets1,108,470529,084
Property and equipment:  
Land and land improvements26,01725,940
Buildings191,491189,148
Manufacturing equipment316,930299,089
Furniture and fixtures63,04461,128
Leasehold improvements53,63849,673
Construction-in-progress61,43961,269
Total property and equipment712,559686,247
Less accumulated depreciation(329,036)(303,271)
Property and equipment - net383,523382,976
Other assets:  
Goodwill382,240359,821
Deferred income tax assets7,2886,599
Right-of-use operating lease assets63,04765,262
Other assets54,79344,352
Total other assets833,251751,906
Total assets2,325,2441,663,966
Current liabilities:  
Trade payables65,94468,504
Accrued expenses120,447123,189
Current portion of long-term debt 11,250
Short-term operating lease liabilities12,08711,005
Income taxes payable5,0866,697
Total current liabilities203,564220,645
Long-term debt823,013186,759
Deferred income tax liabilities5,54718,462
Long-term income taxes payable347347
Liabilities related to unrecognized tax benefits1,9121,912
Deferred compensation payable17,16715,264
Deferred credits1,6051,708
Long-term operating lease liabilities56,25959,736
Other long-term obligations13,83014,736
Total liabilities1,123,244519,569
Commitments and contingencies
Stockholders' equity:  
Preferred stock - 5,000 shares authorized as of December 31, 2023 and December 31, 2022; no shares issued00
Common stock, no par value; 100,000 shares authorized; issued and outstanding as of December 31, 2023 - 57,858 and December 31, 2022 - 57,306638,150675,174
Retained earnings575,184480,773
Accumulated other comprehensive loss(11,334)(11,550)
Total stockholders' equity1,202,0001,144,397
Total liabilities and stockholders' equity2,325,2441,663,966
Developed technology  
Other assets:  
Intangible assets:283,999237,522
Other  
Other assets:  
Intangible assets:$ 41,884$ 38,350
MMSI
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. It operates in two segments, Cardiovascular and Endoscopy. The company provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.
 CEO
 WEBSITEmerit.com
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES6846

Merit Medical Systems Inc Frequently Asked Questions


What is the ticker symbol for Merit Medical Systems Inc? What does MMSI stand for in stocks?

MMSI is the stock ticker symbol of Merit Medical Systems Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Merit Medical Systems Inc (MMSI)?

As of Wed Apr 17 2024, market cap of Merit Medical Systems Inc is 4.14 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of MMSI stock?

You can check MMSI's fair value in chart for subscribers.

What is the fair value of MMSI stock?

You can check MMSI's fair value in chart for subscribers. The fair value of Merit Medical Systems Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Merit Medical Systems Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for MMSI so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Merit Medical Systems Inc a good stock to buy?

The fair value guage provides a quick view whether MMSI is over valued or under valued. Whether Merit Medical Systems Inc is cheap or expensive depends on the assumptions which impact Merit Medical Systems Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for MMSI.

What is Merit Medical Systems Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Apr 17 2024, MMSI's PE ratio (Price to Earnings) is 43.88 and Price to Sales (PS) ratio is 3.29. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. MMSI PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Merit Medical Systems Inc's stock?

In the past 10 years, Merit Medical Systems Inc has provided 0.185 (multiply by 100 for percentage) rate of return.